Onyx Biotec shareholders and shareholding pattern
NSE: ONYXPharmaceuticals & Biotechnology
Last close ₹37.00₹0.00 (0.00%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹37.00.
52-week range of traded prices to 23 Oct 2026
₹24.20Low, 22 May 2026₹49.65High, 5 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹67 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 May 2026
- −0.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 0.27
- Volume, NSEVolume. Shares traded on the last trading day.
- 4,000
Who owns Onyx Biotec, filing by filing
Per cent of the company's shares. Every filing on record, from Mar 2025; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters41.74%
- Foreign institutions0.22%
- Indian institutions2.39%
- Individuals and others55.64%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Mar 2025Filed 15 Apr | Sep 2025Filed 13 Oct | Mar 2026Filed 7 Apr | Sep 2026Filed 21 Oct |
|---|---|---|---|---|
| 65.10% | 65.10% | 65.10% | 41.74% | |
| Indian promoters | 65.10% | 65.10% | 65.10% | 41.74% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 34.90% | 34.90% | 34.90% | 58.26% |
| Shares in issue | 1,81,32,200 | 1,81,32,200 | 1,81,32,200 | 1,81,32,200 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 1,33,22,200 | 1,33,22,200 | 37,00,000 | 37,00,000 |
| Promoters' shares locked in | 1,18,03,200 | 1,18,03,200 | 37,00,000 | 37,00,000 |
A dash is a line the filing did not state.
Onyx Biotec promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is NARESH KUMAR, 23.97%. The filing names 42 more members with no shares.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| NARESH KUMARIndividuals and Hindu undivided familiesHindu undivided family. A family the tax law treats as one holder: property held in the family's name, shared by its members and managed by one of them. | 23.97% | 43,47,000 | 40.26% |
| FATEH PAL SINGHIndividuals and Hindu undivided families | 11.57% | 20,97,600 | 40.52% |
| SANJAY JAINIndividuals and Hindu undivided families | 6.18% | 11,20,600 | 98.16% |
| Riya ChadhaIndividuals and Hindu undivided families | 0.02% | 4,000 | 0.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Onyx Biotec, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2025Filed 15 Apr | Sep 2025Filed 13 Oct | Mar 2026Filed 7 Apr | Sep 2026Filed 21 Oct |
|---|---|---|---|---|
| KUNAL BHARDWAJResident individuals, over ₹2 lakh at face value | – | – | – | 15.01% |
| KANHAIYA BHARDWAJResident individuals, over ₹2 lakh at face value | – | – | – | 3.85% |
| TUSHAR KINKERResident individuals, over ₹2 lakh at face value | – | – | – | 3.78% |
| APNEET KAHLON .Resident individuals, over ₹2 lakh at face value | – | 1.44% | 1.65% | 2.48% |
| GAUTAM BHARDWAJResident individuals, over ₹2 lakh at face value | – | – | – | 2.43% |
| INVICTA CONTINUUM FUND IAlternative investment funds | 2.39% | 2.39% | 2.39% | 2.39% |
| INVICTA CAPSERVCompanies | 1.52% | 1.52% | 1.52% | 1.52% |
| MONIKA UDAY SHAHResident individuals, over ₹2 lakh at face value | – | – | – | 1.38% |
| PROGNOSIS SECURITIES PRIVATE LIMITEDCompanies | – | 1.53% | 1.52% | – |
| KADAYAM RAMANATHAN BHARATResident individuals, over ₹2 lakh at face value | 1.10% | 1.10% | 1.10% | – |
| KINGSMAN WEALTH FUND PCC KIF - LLForeign portfolio investors, category I | 1.10% | 1.10% | – | – |
| ACINTYO INVESTMENT FUND PCC- CELL 1Foreign portfolio investors, category I | 2.57% | – | – | – |
| MARWADI SHARES & FINANCE LIMITEDCompanies | 2.02% | – | – | – |
| ZETA GLOBAL FUNDS (OEIC) PCC LIMITED-ZETA SERIES B FUND PCForeign portfolio investors, category I | 1.52% | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.